{{Rsnum
|rsid=3211938
|Gene=CD36
|Chromosome=7
|position=80671133
|Orientation=plus
|ReferenceAllele=T
|GMAF=0.03306
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=CD36
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 0.0 | 0.0 | 100.0
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.0 | 100.0
| YRI | 11.7 | 40.7 | 47.6
| ASW | 1.8 | 10.5 | 87.7
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 12.7 | 87.3
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}

{{PMID|18305138|OA=1
}} 2020 African Americans. rs3211938, previously shown to influence [[malaria]] susceptibility, is documented to result in CD36 deficiency in a homozygous subject. This SNP conferred protection against the Metabolic Syndrome (p=0.0012, OR= 0.61, 95%CI: 0.46-0.82), increased high-density lipoprotein cholesterol, HDL-C (p=0.00018), and decreased triglycerides (p=0.0059)

{{PMID Auto
|PMID=19403559
|Title=Positive selection of a CD36 nonsense variant in sub-Saharan Africa, but no association with severe malaria phenotypes
|OA=1
}}

{{omim
|desc=CD36 ANTIGEN; CD36
|id=173510
|rsnum=3211938
}}

{{omim
|id=605552
|rsnum=3211938
}}

{{PMID Auto
|PMID=17668374
|Title=Combining evidence of natural selection with association analysis increases power to detect malaria-resistance variants.
|OA=1
}}

{{PMID Auto
|PMID=19055786
|Title=Variations in host genes encoding adhesion molecules and susceptibility to falciparum malaria in India.
|OA=1
}}

{{PMID Auto
|PMID=19064790
|Title=Predictive genomics of cardioembolic stroke.
|OA=1
}}

{{PMID Auto
|PMID=19200524
|Title=A genome-wide survey of the prevalence and evolutionary forces acting on human nonsense SNPs.
|OA=1
}}

{{PMID Auto
|PMID=20585394
|Title=Transforming growth factor beta 2 and heme oxygenase 1 genes are risk factors for the cerebral malaria syndrome in Angolan children.
|OA=1
}}

{{PMID Auto
|PMID=20935172
|Title=Common CD36 SNPs reduce protein expression and may contribute to a protective atherogenic profile.
|OA=1
}}

{{GET Evidence
|gene=CD36
|aa_change=Tyr325Stop
|aa_change_short=Y325X
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs3211938
|overall_frequency_n=299
|overall_frequency_d=10758
|overall_frequency=0.0277933
|n_genomes=5
|n_genomes_annotated=0
|n_haplomes=5
|n_articles=0
|n_articles_annotated=0
|gene_in_genetests=Y
|genetests_testable=Y
|nblosum100=10
|autoscore=4
|n_web_uneval=1
}}

{{PMID Auto
|PMID=23844572
|Title=CD36 Gene Variants and Their Association with Type 2 Diabetes in an Indian Population
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}